Bionik Laboratories

OTC BNKL
$0.10 0.0000 0.0000%
Today share price
Canada
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 32 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

558.94K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

368.02K
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-0.65
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

5.59M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events Bionik Laboratories

All events
No upcoming events scheduled

Stock chart Bionik Laboratories

Stock analysis Bionik Laboratories

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-0.05 -0.05
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

0.04 0.04
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-0.08 -0.08
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

0.04 0.04
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-413.60 -413.60

Price change Bionik Laboratories per year

1.10$ 3.40$
Min Max

Summary analysis Bionik Laboratories

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Bionik Laboratories

Revenue and net income Bionik Laboratories

All parameters

Stock news Bionik Laboratories

All news

About company Bionik Laboratories

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion ARM that allows clinicians to deliver sensor motor therapy to the shoulder and elbow to develop new neural pathways; InMotion ARM\/HAND for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion WRIST, a rehabilitation device that enables clinicians to deliver optimum intensive sensor motor wrist and forearm therapy to patients with neurological conditions. The company also engages in developing InMotion HOME, an upper extremity product that allows patients to extend their therapy for as long as needed while rehabilitating at home; ARKE, a robotic lower body exoskeleton designed for wheelchair bound individuals suffering from spinal cord injuries, strokes, and other mobility disabilities; and InMotion Connect, a solution to meet the data connectivity and analytics needs of hospitals and healthcare facilities. Bionik Laboratories Corp. was founded in 2010 and is headquartered in Toronto, Canada.
Address:
Company name: Bionik Laboratories
Issuer ticker: BNKL
Country: Canada
Exchange: OTC
Currency: $
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site:

On which stock exchange are Bionik Laboratories (BNKL) stocks traded?

Bionik Laboratories (BNKL) stocks are traded on OTC.

What is the ticker of Bionik Laboratories stocks (BNKL)?

The stock ticker of Bionik Laboratories’s stocks or in other words, the code is BNKL. The stocks are currently listed on the OTC exchange.

In which sector and industry does Bionik Laboratories (BNKL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Bionik Laboratories (BNKL) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are Bionik Laboratories (BNKL) stocks traded?

Bionik Laboratories (BNKL) stocks are traded on the OTC exchange in dollars.

What is the price of Bionik Laboratories (BNKL) stocks today?

The current price of Bionik Laboratories stocks on 16.05.2024 is 0.1 dollars. per share.

What is the dynamics of Bionik Laboratories (BNKL) stocks from the beginning of the year?

Bionik Laboratories (BNKL) quotes have increased by 0% from the beginning of the year up to 0.1 dollars. per 1 stocks.

How much did Bionik Laboratories (BNKL) stocks increase in мае 2024?

This month Bionik Laboratories (BNKL) quotes have increased by 0% to 0.1 dollars. per share.

How much are Bionik Laboratories (BNKL) stocks worth?

Today, on October, 16.05.2024 Bionik Laboratories’s (BNKL) stocks cost 0.1 dollars..

What is the market capitalization of Bionik Laboratories (BNKL)?

Capitalization is the market value of Bionik Laboratories (BNKL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Bionik Laboratories (BNKL) is estimated at about 558938 dollars.